Skip to content
Trial Eligibility
Menu

Effect of Methadone and Hydromorphone on the QT Interval After Anesthesia and Surgery

NCT03893734

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

A number of drugs used in the perioperative period may cause prolongation of the QT interval on the electrocardiogram (EKG). These drugs include inhalational agents, antiemetic agents, pain medications, and drugs used to reverse the effects of muscle relaxants. Approximately 80% of patients undergoing a general anesthetic will demonstrate significant prolongation of the QT interval on the EKG in the postanesthesia care unit (PACU) following surgery. The concern with QT interval prolongation is that it can result in a potentially lethal ventricular arrhythmia termed torsade des pointes.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • EKG-QT Prolongation

Eligibility basics and study details

Study type
Interventional
Phase
Phase 4
Ages
18 to 80 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Endeavor Health
Last updated on ClinicalTrials.gov
September 13, 2019

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Illinois · 1

  • NorthShore University HealthSystem · Evanston, IL

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.